Do you want to read an article? Please log in or register.
A Propensity Score Matching Study Between Microwave Ablation and Radiofrequency Ablation in Terms of Safety and Efficacy for Benign Thyroid Nodules Treatment
Thyroid
Related content
RECOMMENDED
Thyroid
A THYROID GENETIC CLASSIFIER CORRECTLY PREDICTS BENIGN NODULES WITH INDETERMINATE CYTOLOGY: TWO-INDEPENDENT MULTICENTER, PROSPECTIVE VALIDATION TRIALS
★ 1
Recommended by
Prof. emer. Dr Ulrich Keller, Faculty Member
Thyroid.
Zafereo M, McIver B, Vargas S, Domínguez Ruiz-Tagle JM, Steward D, Holsinger FC, Kandil E, Williams MD, Cruz F, Loyola S, Solar A, Roa JC, Leon A, Droppelmann N, Arias T, Lobos M, Kong CS, Busaidy N, Grubbs EG, Graham PH, Stewart J, Tang A, Wang J, Orloff LA, Hernríquez-Henríquez M, Lagos M, Wohllk N, Diaz RE, Véliz J, Horvath E, Tala H, Pineda P, Arroyo P, Vasquez F, Osorio M, Schacter D, Franco C, Medina F, Traipe E, Marin L, Miranda G, Bruce E, Bracamonte Nole M, Mena N, Gonzalez H
doi: 10.1089/thy.2019.0490.
COMMENTED
Thyroid
Recurrence after low-dose radioiodine ablation and recombinant human thyroid-stimulating hormone for differentiated thyroid cancer (HiLo): long-term results of an open-label, non-inferiority randomised controlled trial
Lancet Diabetes Endocrinol.
Dehbi HM, Mallick U, Wadsley J, Newbold K, Harmer C, Hackshaw A
doi: 10.1016/S2213-
Diabetes - GeneralType 2 DiabetesGlycemic Control
Effectiveness and safety of long-term treatment with sulfonylureas in patients with neonatal diabetes due to KCNJ11 mutations: an international cohort study
doi: 10.1016/S2213-
COMMENTED
Thyroid
Ultrasound-Guided Radiofrequency Ablation Versus Surgical Resection for the Treatment of T1bN0M0 Papillary Thyroid Carcinoma in Different Age Groups
★ 1
Recommended and commented by
Prof. emer. Dr Ulrich Keller, Faculty Member
Front Endocrinol (Lausanne)
He H, Wu R, Zhao J, Song Q, Zhang Y, Luo Y
doi: 10.3389/fendo.2021.734432
COMMENTED
Thyroid
The long-term outcome of treatment for Graves' hyperthyroidism
Thyroid.
Sjölin G, Holmberg M, Törring O, Byström K, Khamisi S, de Laval D, Abraham-Nordling M, Calissendorff J, Lantz M, Hallengren B, Filipsson Nyström H, Wallin G
doi: 10.1089/thy.2019.0085.
COMMENTED
Type 1 Diabetes
Long-term efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (the DEPICT-2 study): 52-week results from a randomized controlled trial
★ 1
Recommended and commented by
Prof. emer. Dr Ulrich Keller, Faculty Member
doi: 10.1111/dom.14060.
Diabetes - GeneralType 1 DiabetesGlycemic Control
Efficacy and Safety of Mini-dose Glucagon for Treatment of Non-severe Hypoglycemia in Adults with Type 1 Diabetes
J Clin Endocrinol Metab.
Haymond MW, DuBose SN, Rickels MR, Wolpert H, Shah VN, Sherr JL, Weinstock RS, Agarwal S, Verdejo AS, Cummins MJ, Newswanger B, Beck RW; T1D Exchange Mini-dose Glucagon Study Group
doi: 10.1210/jc.2017-00591.
Thyroid
Natural history, treatment, and long-term follow up of patients with multiple endocrine neoplasia type 2B: an international, multicentre, retrospective study
Lancet Diabetes Endocrinol.
Castinetti F, Waguespack SG, Machens A, Uchino S, Lazaar K, Sanso G, Else T, Dvorakova S, Qi XP, Elisei R, Maia AL, Glod J, Lourenço DM Jr, Valdes N, Mathiesen J, Wohllk N, Bandgar TR, Drui D, Korbonits M, Druce MR, Brain C, Kurzawinski T, Patocs A, Bugalho MJ, Lacroix A, Caron P, Fainstein-Day P, Borson Chazot F, Klein M, Links TP, Letizia C, Fugazzola L, Chabre O, Canu L, Cohen R, Tabarin A, Spehar Uroic A, Maiter D, Laboureau S, Mian C, Peczkowska M, Sebag F, Brue T, Mirebeau-Prunier D, Leclerc L, Bausch B, Berdelou A, Sukurai A, Vlcek P, Krajewska J, Barontini M, Vaz Ferreira Vargas C, Valerio L, Ceolin L, Akshintala S, Hoff A, Godballe C, Jarzab B, Jimenez C, Eng C, Imai T, Schlumberger M, Grubbs E, Dralle H, Neumann HP, Baudin E
doi: 10.1016/S2213-8587(18)30336-X.
COMMENTED
Diabetes - GeneralType 2 DiabetesGlycemic Control
A Randomized Clinical Trial of the Efficacy and Safety of Sitagliptin Compared with Dapagliflozin in Patients with Type 2 Diabetes Mellitus and Mild Renal Insufficiency: The CompoSIT-R Study
Diabetes Obes Metab.
Scott R, Morgan J, Zimmer Z, Lam RLH, O'Neill EA, Kaufman KD, Engel SS, Raji A
doi: 10.1111/dom.13473.